EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Primary care screening for sexually transmitted infections in the United States from 2019 to 2021

Shiying Hao iD, Esther E Velásquez iD, William S Pearson, Karen W Hoover, Weiming Zhu, Ilia Rochlin, Ayin Vala, Isabella Chu, Robert L Phillips, David H Rehkopf, Neil Kamdar

PLOS One · 02.06.2025 · 20 (6) · e0325097

DOI: 10.1371/journal.pone.0325097 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS One, online erschienen am 02.06.2025. Verfasst von Shiying Hao und 10 weiteren Autor:innen. Beteiligte Einrichtung: Center for Population Health Sciences, School of Medicine, Stanford University, Palo Alto, California, United States of America. Hauptthemen laut MEDLINE: Primary Health Care, Sexually Transmitted Diseases, Mass Screening. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: JG CDC HHS, Centers for Disease Control and Prevention.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Early identification and treatment of sexually transmitted infections (STIs) is critical to improve patient outcomes. Barriers to healthcare seeking are potentially exacerbated by COVID-19. This study examined trends in STI testing and positivity from 2019 to 2021 in primary care in the United States.

Methods

This is a retrospective study using the PRIME Registry, a national primary care EHR registry, from January 1, 2019-December 31, 2021. We calculated age-standardized monthly and annual testing rates for chlamydia, gonorrhea, syphilis, and human immunodeficiency virus stratified by gender and race/ethnicity. We also generated quarterly and annual rates for test positivity. Chi-square tests and 95% confidence intervals were used for comparison. 753 practices and 4,410,609 patients were included, with 180,558 having STI tests.

Results

We observed a substantial decline in testing rates for STIs from March-April 2020 (31% for chlamydia, 30% for gonorrhea, 23% for syphilis, 24% for HIV), followed by a rapid increase in May-June 2020 (64% for chlamydia, 65% for gonorrhea, 32% for syphilis, 48% for HIV). Testing rates per 100,000 decreased from 2019 to 2021 for chlamydia (3,592 vs 2,355 vs 2,181) while increased for gonorrhea in 2020 (2,129 vs 2,207 vs 2,057). STI testing rates from 2019 to 2021 for females and non-Hispanic Black or African American patients were higher than other groups. An increase in test positivity from 2019 to 2021 was observed for gonorrhea (0.4% vs 0.4% vs 0.5%) but no significant change for chlamydia (1.5% vs 1.6% vs 1.5%).

Conclusion

Testing rates for STIs substantially dropped during stay-at-home orders early in the pandemic and recovered after these were relaxed. Gender and race/ethnicity STI testing differences may reflect primary care’s prioritization of higher risk populations. This study emphasizes the role of primary care EHR data in monitoring and an opportunity for closer collaboration with public health agencies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Primary Health CareSexually Transmitted DiseasesMass ScreeningHumansFemaleUnited StatesMaleRetrospective StudiesAdultMiddle AgedAdolescentYoung AdultCOVID-19GonorrheaChlamydia InfectionsSyphilisHIV Infections

Autor:innen und Institutionen

  • Center for Population Health Sciences, School of Medicine, Stanford University, Palo Alto, California, United States of America.
  • Division of STD Prevention, Centers for Disease Control and Prevention, Atlanta, GeorgiaUnited States of America.
  • Division of HIV Prevention, Centers for Disease Control and Prevention, Atlanta, GeorgiaUnited States of America.
  • Inform and Disseminate Division, Office of Public Health Data, Surveillance, and Technology, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.
  • The Center for Professionalism & Value in Health Care, ABFM Foundation, Seattle, Washington, D.C., United States of America.
  • Department of Epidemiology and Population Health, School of Medicine, Stanford University, Stanford, California, United States of America.

ORCID-Profile: Shiying Hao, Esther E Velásquez

Förderung

  • JG CDC HHS
  • Centers for Disease Control and Prevention

Zitieren

APA

Hao, S., Velásquez, E. E., Pearson, W. S., Hoover, K. W., Zhu, W., Rochlin, I., Vala, A., Chu, I., Phillips, R. L., Rehkopf, D. H., & Kamdar, N. (2025). Primary care screening for sexually transmitted infections in the United States from 2019 to 2021. PLOS One, 20(6), e0325097. https://doi.org/10.1371/journal.pone.0325097

Vancouver

Hao S, Velásquez EE, Pearson WS, Hoover KW, Zhu W, Rochlin I, et al. Primary care screening for sexually transmitted infections in the United States from 2019 to 2021. PLOS One. 2025;20(6):e0325097. doi:10.1371/journal.pone.0325097

BibTeX
@article{Hao2025,
  author = {Hao, Shiying and Velásquez, Esther E and Pearson, William S and Hoover, Karen W and Zhu, Weiming and Rochlin, Ilia and Vala, Ayin and Chu, Isabella and Phillips, Robert L and Rehkopf, David H and Kamdar, Neil},
  title = {Primary care screening for sexually transmitted infections in the United States from 2019 to 2021},
  journal = {PLOS One},
  year = {2025},
  volume = {20},
  number = {6},
  pages = {e0325097},
  doi = {10.1371/journal.pone.0325097}
}
Kostenlos starten →